Musaffa Logo

VVOS Shariah Compliance

Screening Methodology: AAOIFI

As of July 2026, Vivos Therapeutics Inc is classified as not halal.

NOT HALAL

Report Source: 2026 1st Quarter Report

Vivos Therapeutics Inc

Vivos Therapeutics Inc. Stock Analysis VVOS

United States Health Care Nano Cap Report:
Vivos Therapeutics, Inc. is a medical technology company which engages in the development and commercialization of treatment alternatives for patients with sleep disordered breathing (SDB). The company is headquartered in Littleton, Colorado and currently employs 268 full-time employees. The company went IPO on 2020-12-11. The firm's Complete Airway Repositioning and/or Expansion (CARE) devices are the oral appliances cleared by the United States Food and Drug Administration (FDA) for adult patients diagnosed with all severity levels of OSA (including severe OSA) and moderate-to-severe OSA in children ages 6 to 17 within the FDA cleared usage for such devices. The firm's products and services include Vivos CARE oral appliance therapy, Vivos oral appliances and therapies outside of CARE system, Vivos AireO2, Adjunctive Treatment, Treatment Navigator, Vivos Billing Intelligence Service (BIS) and Vivos Airway Intelligence Service, and others. The firm has sleep testing centers and associated medical sleep practice.
Read More

Vivos Therapeutics Inc (VVOS) Chart

Key Statistics of Vivos Therapeutics Inc (VVOS)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$0.41$0.44

Today's Open

$0.43

Volume

181.55K

P/E Ratio (TTM)

-

52 Week Range

$0.38$6.46

Market Cap

7.57M

Avg. Volume

896.02K

Dividend Yield

-

Financial Metrics & Statements of Vivos Therapeutics Inc (VVOS)

Super Investors Invested in Vivos Therapeutics Inc (VVOS)

FAQ's for Vivos Therapeutics Inc (VVOS)

  • As of July 2026, Vivos Therapeutics Inc VVOS is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
  • A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Vivos Therapeutics Inc using these criteria to determine its compliance status.
  • Muslim investors may consider investing in Vivos Therapeutics Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
  • Musaffa determines the Shariah status of Vivos Therapeutics Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
  • The Shariah compliance status of Vivos Therapeutics Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
  • Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
  • You can check the latest Shariah compliance status of Vivos Therapeutics Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.